Cargando…
Neonatal Bacillus Calmette-Guérin Vaccination to Prevent Early-Life Eczema: A Systematic Review and Meta-analysis
Increasing evidence suggests that early-life bacillus Calmette-Guérin (BCG) vaccine could prevent atopic eczema through its beneficial off-target effects. In this meta-analysis, 3 randomized control trials with similar methods were included and enabled robust estimations with low heterogeneity, invo...
Autores principales: | Pittet, Laure F., Thøstesen, Lisbeth M., Aaby, Peter, Kofoed, Poul-Erik, Curtis, Nigel, Benn, Christine S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674447/ https://www.ncbi.nlm.nih.gov/pubmed/36125788 http://dx.doi.org/10.1097/DER.0000000000000945 |
Ejemplares similares
-
Bacillus Calmette-Guérin vaccination, thymic size, and thymic output in healthy newborns
por: Birk, Nina Marie, et al.
Publicado: (2017) -
The association between Bacillus Calmette-Guérin vaccination (1331 SSI) skin reaction and subsequent scar development in infants
por: Birk, Nina Marie, et al.
Publicado: (2017) -
Effects of Bacillus Calmette-Guérin (BCG) vaccination at birth on T and B lymphocyte subsets: Results from a clinical randomized trial
por: Birk, Nina Marie, et al.
Publicado: (2017) -
Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021) -
The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines
por: Villanueva, Paola, et al.
Publicado: (2022)